Αποτελέσματα Αναζήτησης
10 Δεκ 2019 · Non-malignancy-related side effects of our keloid radiotherapy protocol. Radiotherapy also associates with a number of benign side effects, including telangiectasia, hyperpigmentation and hypopigmentation.
- Open in a Separate Window
Recurrence rates of consecutive excised keloids on various...
- Keloids and the Hallmarks of Cancer
Many important tumor-related factors, which have been shown...
- Open in a Separate Window
31 Μαρ 2021 · Side effects of radiation can be grouped into acute side effects, related to the total dose of radiation, and late side effects, related to the dose given per fraction. 8 Acute changes include erythema, edema, and pain, and typically occur within the first days to weeks after treatment.
10 Δεκ 2019 · Keloids can be treated in a number of ways, including by surgery. Multiple studies now show that while surgical monotherapy associates with extremely high rates of recurrence (50%–80%), postoperative radiotherapy can significantly reduce these recurrence rates.
30 Απρ 2021 · Female patients with keloids were vulnerable to pancreatic cancer (RR = 2.39, P = 0.0293) but protected from breast cancer (RR = 0.55, 95% CI = 0.43–0.78), colon cancer (RR = 0.66, 95% CI...
19 Ιαν 2023 · If you need radiation therapy as a part of your breast cancer treatment, you may have questions about side effects. What are the most common side effects, for instance? How long will they last? And, is there any way to prevent or reduce them?
Common side effects include permanent hypo- and hyperpigmentation, blistering, and postoperative pain , and a delay of approximately 3–4 weeks between sessions (approximately three to six sessions are needed) is often needed for post treatment healing [35,36].
7 Αυγ 2019 · Many important tumor-related factors, which have been shown to contribute to the overall pathogenesis by influencing cellular processes such as apoptosis. To this point in time, the use of cancer treatments in keloids has shown encouraging results, further diminishing the fine line between keloids and cancerous tumors.
